Javier Guillermo
Cassinello Espinosa
Profesor/a Asociado/a en CC. de la Salud
Hospital Miguel Servet
Zaragoza, EspañaPublicaciones en colaboración con investigadores/as de Hospital Miguel Servet (6)
2022
-
A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial
European Journal of Cancer, Vol. 175, pp. 110-119
2021
-
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis
Drugs and Aging, Vol. 38, Núm. 3, pp. 219-231
2018
-
Preliminary safety results of the randomized phase II ABIDO-SOGUG trial: Toxicity profile of concomitant abiraterone acetate + docetaxel treatment in comparison to docetaxel
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii286
2016
-
Quality indicators to assure and improve cancer care in Spain using the delphi technique
JNCCN Journal of the National Comprehensive Cancer Network, Vol. 14, Núm. 5, pp. 553-558
2012
-
Pain in clinical oncology: patient satisfaction with management of cancer pain.
European journal of pain (London, England), Vol. 16, Núm. 3, pp. 381-389
1995
-
METASTASIS EN SISTEMA NERVIOSO CENTRAL POR CARCINOMA PAPILAR DE TIROIDES BIEN DIFERENCIADO
Oncologia, Vol. 18, Núm. 11, pp. 63-66